Metropolitan Life Insurance Company (MetLife)’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,474
Closed -$185K 1049
2024
Q1
$185K Sell
12,474
-892
-7% -$13.2K 0.01% 749
2023
Q4
$109K Hold
13,366
0.01% 1031
2023
Q3
$60.8K Buy
13,366
+1,997
+18% +$9.09K ﹤0.01% 1293
2023
Q2
$80K Buy
+11,369
New +$80K ﹤0.01% 1140
2023
Q1
Sell
-9,119
Closed -$58.3K 2386
2022
Q4
$58.3K Hold
9,119
﹤0.01% 1374
2022
Q3
$87.4K Hold
9,119
﹤0.01% 1092
2022
Q2
$101K Buy
+9,119
New +$101K ﹤0.01% 1048
2022
Q1
Sell
-5,082
Closed -$97K 2458
2021
Q4
$97K Buy
5,082
+42
+0.8% +$802 ﹤0.01% 2505
2021
Q3
$124K Buy
+5,040
New +$124K ﹤0.01% 2399
2021
Q2
Sell
-10,013
Closed -$317K 2786
2021
Q1
$317K Sell
10,013
-451
-4% -$14.3K ﹤0.01% 1716
2020
Q4
$486K Sell
10,464
-204
-2% -$9.47K 0.01% 1367
2020
Q3
$351K Sell
10,668
-77
-0.7% -$2.54K 0.01% 1443
2020
Q2
$295K Sell
10,745
-24,719
-70% -$679K 0.01% 1555
2020
Q1
$1.06M Sell
35,464
-1,094
-3% -$32.7K 0.02% 650
2019
Q4
$1.01M Sell
36,558
-682
-2% -$18.9K 0.02% 897
2019
Q3
$678K Buy
37,240
+1,855
+5% +$33.8K 0.01% 1101
2019
Q2
$868K Hold
35,385
0.01% 976
2019
Q1
$337K Hold
35,385
0.01% 1555
2018
Q4
$313K Buy
35,385
+8,010
+29% +$70.9K 0.01% 1526
2018
Q3
$308K Buy
+27,375
New +$308K 0.01% 1698
2017
Q2
Sell
-37,345
Closed -$278K 2576
2017
Q1
$278K Hold
37,345
﹤0.01% 2059
2016
Q4
$260K Hold
37,345
﹤0.01% 2176
2016
Q3
$307K Buy
37,345
+1,248
+3% +$10.3K ﹤0.01% 2050
2016
Q2
$292K Hold
36,097
﹤0.01% 2066
2016
Q1
$183K Hold
36,097
﹤0.01% 2227
2015
Q4
$279K Buy
36,097
+4,242
+13% +$32.8K ﹤0.01% 2019
2015
Q3
$183K Sell
31,855
-7,128
-18% -$40.9K ﹤0.01% 2346
2015
Q2
$357K Buy
+38,983
New +$357K ﹤0.01% 1986